Prostate Cancer News and Research

Latest Prostate Cancer News and Research

New molecule kills a broad spectrum of hard-to-treat cancers

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs.

10 Jun 2022

Androgens contribute to sex bias in bladder cancer

Male sex hormones interfere with the body's ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.

10 Jun 2022

Higher intake of dairy foods associated with increased prostate cancer risk

Men with higher intakes of dairy foods, especially milk, face a significantly higher risk of prostate cancer compared to men with lower intakes, according to a new study conducted by researchers at Loma Linda University Health.

9 Jun 2022

Study describes one of the first entirely new drug delivery microencapsulation approaches in decades

A new study from the University of Michigan describes one of the first entirely new drug delivery microencapsulation approaches in decades.

8 Jun 2022

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Quenton Tompkins' family tree is deeply rooted in rural McCormick County, South Carolina.

6 Jun 2022

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

Patients newly diagnosed with cancer typically focus on one question, eclipsing all others: "What is my prognosis?"

2 Jun 2022

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Inviting people who don't have symptoms to be screened for prostate cancer is not currently recommended and should be approached with caution because, for most men, the benefit is small and uncertain and there are clear harms, warn experts in The BMJ today.

1 Jun 2022

Physicians should have rudimentary knowledge of the benefits of plant-based diet for six health conditions

A new commentary in the American Journal of Lifestyle Medicine says that all physicians should be aware of the benefits of a plant-based diet for six health conditions: weight loss and maintenance, cardiovascular disease, cancer, diabetes, Alzheimer's disease, and COVID-19.

31 May 2022

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study published in the Journal of Clinical Oncology.

31 May 2022

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

27 May 2022

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy - a commonly used hormone injection - plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

26 May 2022

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers found.

25 May 2022

The link between androgens and COVID-19

A new paper examines the association between androgens and COVID-19, as revealed by the research carried out on this topic throughout the pandemic.

20 May 2022

Black people continue to bear a higher cancer burden even after steady decline in mortality rates

From 1999 to 2019, rates of cancer deaths declined steadily among Black people in the United States. Nevertheless, in 2019, Black people still had considerably higher rates of cancer death than people in other racial and ethnic groups, a large epidemiologic study has found.

19 May 2022

Researchers show the feasibility of a comprehensive sequencing approach in pediatric and young adult cancers

New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach on 114 pediatric, adolescent, and young adult patients with solid tumors.

18 May 2022

Insight into sustained-release drug delivery systems

In this interview, News-Medical speaks to Thanh T. Nguyen, a project manager at Innocore Pharmaceuticals, about the mechanisms behind long-acting injectables.

From Thermo Fisher Scientific – Materials Characterization 18 May 2022

New technology may pave the way for development of point-of-care devices and diagnostic tests

Biomarkers are components that may be present in biological samples and are related to specific diseases. Therefore, doctors can analyze biological samples from a patient to check their health condition or to monitor the progress of a specific therapy.

17 May 2022

Researchers discover new gene that confers resistance to prostate cancer treatment

Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.

13 May 2022

New MRI nanotechnology designed to precisely image aggressive brain tumors

A novel technology designed to precisely image aggressive brain cancers and guide treatment is being developed by the University of South Australia and Australian cancer diagnostic company, Ferronova, potentially helping thousands of people who are diagnosed with the deadly condition each year.

12 May 2022

Prostate cancer patients benefit from precision oncology

Researchers at the University of Bern and University Hospital Bern have achieved a breakthrough in a particularly aggressive form of prostate cancer.

11 May 2022

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

New molecule kills a broad spectrum of hard-to-treat cancers

Androgens contribute to sex bias in bladder cancer

Higher intake of dairy foods associated with increased prostate cancer risk

Study describes one of the first entirely new drug delivery microencapsulation approaches in decades

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Physicians should have rudimentary knowledge of the benefits of plant-based diet for six health conditions

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

Discovery of new prostate cancer subtype opens the door to development of therapies

Combined treatment approach proves to be beneficial for prostate cancer patients

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

The link between androgens and COVID-19

Black people continue to bear a higher cancer burden even after steady decline in mortality rates

Researchers show the feasibility of a comprehensive sequencing approach in pediatric and young adult cancers

Insight into sustained-release drug delivery systems

New technology may pave the way for development of point-of-care devices and diagnostic tests

Researchers discover new gene that confers resistance to prostate cancer treatment

New MRI nanotechnology designed to precisely image aggressive brain tumors

Prostate cancer patients benefit from precision oncology

What to know about prostate cancer eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in